Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Paul Czodrowski, Jan M Kriegl, Stefan Scheuerer & Thomas Fox. (2009) Computational approaches to predict drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 5:1, pages 15-27.
Read now
Read now
Sean Ekins, Sergey Andreyev, Andy Ryabov, Eugene Kirillov, Eugene A Rakhmatulin, Andrej Bugrim & Tatiana Nikolskaya. (2005) Computational prediction of human drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 1:2, pages 303-324.
Read now
Read now
E. M. Gifford, M. A. Johnson, D. G. Kaiser & Chun-Che Tsai. (1995) Modelling the relative metabolic occurrence of alkyl-nitrogen bond cleavage using structure-reactivity maps. Xenobiotica 25:8, pages 825-846.
Read now
Read now
E.M. Gifford, M.A. Johnson, D.G. Kaiser & C.C. Tsai. (1994) An Analysis of the Relative Occurrence of N-Demethylation and N-Oxidation in Xenobiotic Metabolism Using Structure-Reactivity Maps. SAR and QSAR in Environmental Research 2:1-2, pages 105-127.
Read now
Read now
Sergey V. Geodakyan. (1993) Methodological Approach in the Study of Anticancer Drug Metabolism: Qualitative Considerations. Drug Metabolism Reviews 25:1-2, pages 153-172.
Read now
Read now
Corwin Hansch & Litai Zhang. (1993) Quantitative Structure-Activity Relationships of Cytochrome P-450. Drug Metabolism Reviews 25:1-2, pages 1-48.
Read now
Read now
Y. H. Park, R. Barker, B. Griffin, D. Barratt, M. Dupriest, K. Brazzell, B. York & P. Mayer. (1992) Pharmacokinetics and efficacy of structurally related spirohydantoin and spirosuccinimide aldose reductase inhibitors. Xenobiotica 22:5, pages 543-550.
Read now
Read now
L. R. Hall & R. P. Hanzlik. (1991) N-Dealkylation of tertiary amides by cytochrome P-450. Xenobiotica 21:9, pages 1127-1138.
Read now
Read now
Corwin Hansch, Donbosco Kim, Albert J. Leo, Ettore Novellino, Carlo Silipo, Antonio Vittoria, James A. Bond & Rogene F. Henderson. (1989) Toward A Quantitative Comparative Toxicology of Organic Compounds. CRC Critical Reviews in Toxicology 19:3, pages 185-226.
Read now
Read now
Carol N. Manners, David W. Payling & Dennis A. Smith. (1988) Distribution coefficient, a convenient term for the relation of predictable physico-chemical properties to metabolic processes. Xenobiotica 18:3, pages 331-350.
Read now
Read now
Dennis A. Smith, Kevan Brown & Michael G. Neale. (1985) Chromone-2-Carboxylic Acids: Roles of Acidity and Lipophilicity in Drug Disposition. Drug Metabolism Reviews 16:4, pages 365-388.
Read now
Read now
JohnR. Froines, EdwardM. Postlethwait, EdwardJ. LaFuente & Wen
Chen Victor Liu. (1985) In vivo and in vitro release of cyanide from neurotoxic aminonitriles. Journal of Toxicology and Environmental Health 16:3-4, pages 449-460.
Read now
Read now
Gábor Maksay & László Ötvös. (1983) Bioactivation of Prodrugs: Structure-Pharmacokinetic Correlations of Benzodiazepine Esters. Drug Metabolism Reviews 14:6, pages 1165-1192.
Read now
Read now
Shih-Chieh Chang & Vincent H.L. Lee. (1982) Influence of chain length on the in vitro hydrolysis of model ester prodrugs by ocular esterases. Current Eye Research 2:10, pages 651-656.
Read now
Read now
H. P. A. Illing & Esther S. A. House. (1981) Effects of detergents and organic solvents on rat liver microsomal UDP-glucuronosyltransferase activity towards phenolic substrates. Xenobiotica 11:10, pages 709-718.
Read now
Read now
Patrick A. F. Dixon, John Caldwell & Robert L. Smith. (1977) Metabolism of Arylacetic Acids: 4. Physico-Chemical, Structural and Biological Factors Influencing the Pattern of Conjugation. Xenobiotica 7:12, pages 727-736.
Read now
Read now
Rolf Schulte-Hermann. (1974) Induction of Liver Growth by Xenobiotic Compounds and Other Stimuli. CRC Critical Reviews in Toxicology 3:1, pages 97-158.
Read now
Read now
Articles from other publishers (72)
P. Ganga Raju Achary, P. Kali Krishna, Alla P. Toropova & Andrey A. Toropov. 2023. QSPR/QSAR Analysis Using SMILES and Quasi-SMILES. QSPR/QSAR Analysis Using SMILES and Quasi-SMILES
241
268
.
Usman Ali Ashfaq, Farah Shahid & Samman Munir. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
29
72
.
Mohammad Sharifian Gh.. (2021) Recent Experimental Developments in Studying Passive Membrane Transport of Drug Molecules. Molecular Pharmaceutics 18:6, pages 2122-2141.
Crossref
Crossref
Imlimaong Aier & Pritish Kumar Varadwaj. 2021. Molecular Docking for Computer-Aided Drug Design. Molecular Docking for Computer-Aided Drug Design
313
336
.
Aman Chandra Kaushik, Ajay Kumar, Shiv Bharadwaj, Ravi Chaudhary & Shakti SahiAman Chandra Kaushik, Ajay Kumar, Shiv Bharadwaj, Ravi Chaudhary & Shakti Sahi. 2018. Bioinformatics Techniques for Drug Discovery. Bioinformatics Techniques for Drug Discovery
1
10
.
Christopher T. Lee, Jeffrey Comer, Conner Herndon, Nelson Leung, Anna Pavlova, Robert V. Swift, Chris Tung, Christopher N. Rowley, Rommie E. Amaro, Christophe Chipot, Yi Wang & James C. Gumbart. (2016) Simulation-Based Approaches for Determining Membrane Permeability of Small Compounds. Journal of Chemical Information and Modeling 56:4, pages 721-733.
Crossref
Crossref
Alexander L. Perryman, Thomas P. Stratton, Sean Ekins & Joel S. Freundlich. (2015) Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data. Pharmaceutical Research 33:2, pages 433-449.
Crossref
Crossref
Luca Settimo, Krista Bellman & Ronald M. A. Knegtel. (2013) Comparison of the Accuracy of Experimental and Predicted pKa Values of Basic and Acidic Compounds. Pharmaceutical Research 31:4, pages 1082-1095.
Crossref
Crossref
Jon A. Arnot, Trevor N. Brown & Frank Wania. (2013) Estimating Screening-Level Organic Chemical Half-Lives in Humans. Environmental Science & Technology 48:1, pages 723-730.
Crossref
Crossref
Robert V. Swift & Rommie E. Amaro. (2013) Back to the Future: Can Physical Models of Passive Membrane Permeability Help Reduce Drug Candidate Attrition and Move Us Beyond QSPR?. Chemical Biology & Drug Design 81:1, pages 61-71.
Crossref
Crossref
A. K. Madan & Harish Dureja. 2012. Computational Toxicology. Computational Toxicology
337
357
.
David Stopher & Siobhan McClean. (1990) An improved method for the determination of distribution coefficients. Journal of Pharmacy and Pharmacology 42:2, pages 144-144.
Crossref
Crossref
Han Van De Waterbeemd, Bernard Testa & John Caldwell. (1986) The influence of conformational factors on the metabolic conjugation of aryloxyacetates. Journal of Pharmacy and Pharmacology 38:1, pages 14-18.
Crossref
Crossref
B Testa & P Jenner. (1976) The concept of regioselectivity in drug metabolism. Journal of Pharmacy and Pharmacology 28:10, pages 731-744.
Crossref
Crossref
John A. Timbrell. 2008. Principles of Biochemical Toxicology. Principles of Biochemical Toxicology
139
202
.
John Timbrell. 2008. Principles of Biochemical Toxicology, Fourth Edition. Principles of Biochemical Toxicology, Fourth Edition
129
191
.
S Ekins, J Mestres & B Testa. (2007)
In silico
pharmacology for drug discovery: methods for virtual ligand screening and profiling
. British Journal of Pharmacology 152:1, pages 9-20.
Crossref
Crossref
Thomas Fox & Jan M. Kriegl. 2007.
63
81
.
Larry J. Jolivette & Sean Ekins. 2007.
131
176
.
P. L. A. Popelier, P. J. Smith & U. A. Chaudry. (2005) Quantitative structure-activity relationships of mutagenic activity from quantum topological descriptors: triazenes and halogenated hydroxyfuranones (mutagen-X) derivatives. Journal of Computer-Aided Molecular Design 18:11, pages 709-718.
Crossref
Crossref
Sean Ekins. (2004) Predicting undesirable drug interactions with promiscuous proteins in silico. Drug Discovery Today 9:6, pages 276-285.
Crossref
Crossref
D. Werdenberg, R. Joshi, S. Wolffram, H.P. Merkle & P. Langguth. (2003) Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharmaceutics & Drug Disposition 24:6, pages 259-273.
Crossref
Crossref
Marcel J. de Groot & Sean Ekins. (2002) Pharmacophore modeling of cytochromes P450. Advanced Drug Delivery Reviews 54:3, pages 367-383.
Crossref
Crossref
Sean Ekins & Steven A Wrighton. (2001) Application of in silico approaches to predicting drug–drug interactions. Journal of Pharmacological and Toxicological Methods 45:1, pages 65-69.
Crossref
Crossref
Sean Ekins, Chris L Waller, Peter W Swaan, Gabriele Cruciani, Steven A Wrighton & James H Wikel. (2000) Progress in predicting human ADME parameters in silico. Journal of Pharmacological and Toxicological Methods 44:1, pages 251-272.
Crossref
Crossref
Ramon Carbó-Dorca, David Robert, Lluís Amat, Xavier Gironés & Emili BesalúRamon Carbó-Dorca, David Robert, Lluís Amat, Xavier Gironés & Emili Besalú. 2000. Molecular Quantum Similarity in QSAR and Drug Design. Molecular Quantum Similarity in QSAR and Drug Design
84
95
.
Štefan Baláž, Michael Wiese & Joachim K. Seydel. (1991) A kinetic description of the fate of chemicals in biosystems. Science of The Total Environment 109-110, pages 357-375.
Crossref
Crossref
Eric Gifford, Mark Johnson & Chun-che Tsai. (1991) A graph-theoretic approach to modeling metabolic pathways. Journal of Computer-Aided Molecular Design 5:4, pages 303-322.
Crossref
Crossref
S. Ferrari, T. Leemann & P. Dayer. (1991) The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro. Life Sciences 48:23, pages 2259-2265.
Crossref
Crossref
A. Bast, A. J. Valk & H. Timmerman. (1990) Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues. Agents and Actions 30:1-2, pages 161-165.
Crossref
Crossref
Alan J. Shusterman & A.Sherwood Johnson. (1990) The role of hydrophobicity and electronic factors in regulating alcohol inhibition of cytochrome P-450-mediated aniline hydroxylation. Chemico-Biological Interactions 74:1-2, pages 63-77.
Crossref
Crossref
Corwin Hansch, Jacqueline F. Sinclair & Peter R. Sinclair. (1990) Induction of Cytochrome P450 by Barbiturates in Chick Embryo Hepatocytes: A Quantitative Structure-Activity Analysis. Quantitative Structure-Activity Relationships 9:3, pages 223-226.
Crossref
Crossref
Alan J. Shusterman, A. Sherwood Johnson & Corwin Hansch. (1989) Correlation of mutagenicity of 1,1-dimethyl-3-(X-phenyl)-triazenes with molecular orbital energies and hydrophobicity. International Journal of Quantum Chemistry 36:1, pages 19-33.
Crossref
Crossref
Karel P.M. Heirwegh, Jules A.T.P. Meuwissen, Peter Van den Steen & Humbert De Smedt. (1989) Modelling of chemical reactions catalysed by membrane-bound enzymes. Determination and significance of the kinetic constants. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 995:2, pages 151-159.
Crossref
Crossref
Rosa L. Lopez De Compadre, Alan J. Shusterman & Corwin Hansch. (1988) The role of hydrophobicity in the Ames test. The correlation of the mutagenicity of nitropolycyclic hydrocarbons with partition coefficients and molecular orbital indices. International Journal of Quantum Chemistry 34:2, pages 91-101.
Crossref
Crossref
Nobutoshi Watari, Yuichi Sugiyama, Nobuyoshi Kaneniwa & Mituru Hiura. (1988) Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure—Pharmacokinetic relationships. Journal of Pharmacokinetics and Biopharmaceutics 16:3, pages 279-301.
Crossref
Crossref
Ronald J. Tallarida, Robert B. Raffa & Paul McGonigleRonald J. Tallarida, Robert B. Raffa & Paul McGonigle. 1988. Principles in General Pharmacology. Principles in General Pharmacology
61
95
.
Ovanes G. Mekenyan, Danail G. Bonchev & Venelin G. Enchev. (1988) Modeling the Interaction of Small Organic Molecules with Biomacromolecules (the Oasis Approach). V. Toxicity of Phenols to Algae âLemna Minorâ. Quantitative Structure-Activity Relationships 7:4, pages 240-244.
Crossref
Crossref
Rosalind J. Martin, Stephen P. Denyer & Jonathan Hadgraft. (1987) Skin metabolism of topically applied compounds. International Journal of Pharmaceutics 39:1-2, pages 23-32.
Crossref
Crossref
Corwin Hansch, J.P. Björkroth & A. Leo. (1987) Hydrophobicity and Central Nervous System Agents: On the Principle of Minimal Hydrophobicity in Drug Design. Journal of Pharmaceutical Sciences 76:9, pages 663-687.
Crossref
Crossref
O.P. Flint. (1986) An In vitro test for teratogens: Its practical application. Food and Chemical Toxicology 24:6-7, pages 627-631.
Crossref
Crossref
B. Jerman-Blaẑiĉ, I. Fabiĉ & M. Randić. (1986) Comparison of sequences as a method for evaluation of the molecular similarity. Journal of Computational Chemistry 7:2, pages 176-188.
Crossref
Crossref
J M Mayer & H van de Waterbeemd. (1985) Development of quantitative structure-pharmacokinetic relationships.. Environmental Health Perspectives 61, pages 295-306.
Crossref
Crossref
Gilles Klopman, Krishnan Namboodiri & Melvin Schochet. (2004) Simple method of computing the partition coefficient. Journal of Computational Chemistry 6:1, pages 28-38.
Crossref
Crossref
Jacek T. Bojarski, Jerzy L. Mokrosz, Henryk J. Bartoń & Maria H. Paluchowska. 1985. Advances in Heterocyclic Chemistry Volume 38. Advances in Heterocyclic Chemistry Volume 38
229
297
.
Aalt Bast, E. Maria Savenije−Chapel & Jan Noordhoek. (1984) Relationship Between Molecular Structure and Cytochrome P450−Metabolic Intermediate Complex Formation. Journal of Pharmaceutical Sciences 73:7, pages 953-956.
Crossref
Crossref
S.C. Basak, D.K. Harriss & V.R. Magnuson. (1984) Comparative Study of Lipophilicity versus Topological Molecular Descriptors in Biological Correlations. Journal of Pharmaceutical Sciences 73:4, pages 429-437.
Crossref
Crossref
S.C. Basak, D.P. Gieschen, D.K. Harriss & V.R. Magnuson. (1983) Physicochemical and Topological Correlates of the Enzymatic Acetyltransfer Reaction. Journal of Pharmaceutical Sciences 72:8, pages 934-937.
Crossref
Crossref
M. Danny Burke & Richard T. Mayer. (1983) Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chemico-Biological Interactions 45:2, pages 243-258.
Crossref
Crossref
V. AUSTEL & E. KUTTER. 1983. Quantitative Structure–Activity Relationships of Drugs. Quantitative Structure–Activity Relationships of Drugs
437
496
.
Gilles Klopman & Linda D. Iroff. (2004) Calculation of partition coefficients by the charge density method. Journal of Computational Chemistry 2:2, pages 157-160.
Crossref
Crossref
B. Testa. (1981) Structural and electronic factors influencing the inhibition of aniline hydroxylation by alcohols and their binding to cytochrome P-450. Chemico-Biological Interactions 34:3, pages 287-300.
Crossref
Crossref
Corwin Hansch. (2008) The physicochemical approach to drug design and discovery (QSAR). Drug Development Research 1:4, pages 267-309.
Crossref
Crossref
Bernard Testa & Bjarne Salvesen. (1980) Quantitative structure–activity relationships in drug metabolism and disposition: Pharmacokinetics of N-substituted amphetamines in humans. Journal of Pharmaceutical Sciences 69:5, pages 497-501.
Crossref
Crossref
Alexandru T. Balaban, Adrian Chiriac, Ioan Motoc & Zeno SimonAlexandru T. Balaban, Adrian Chiriac, Ioan Motoc & Zeno Simon. 1980. Steric Fit in Quantitative Structure-Activity Relations. Steric Fit in Quantitative Structure-Activity Relations
168
178
.
Janet K. Stephens, Francis R. Murphy & Gerald S. Marks. (1978) Drug-induced porphyrin biosynthesis-XVII. Evaluation of the porphyrin-inducing activity of aliphatic mono- and diesters before and after bis(p-nitrophenyl) phosphate treatment of chick embryo liver cells. Biochemical Pharmacology 27:20, pages 2431-2437.
Crossref
Crossref
Gerald S. Marks. 1978. Heme and Hemoproteins. Heme and Hemoproteins
201
237
.
Neal CastagnoliJr.Jr.. 1978. Stimulants. Stimulants
335
387
.
Corwin Hansch. 1978. Correlation Analysis in Chemistry. Correlation Analysis in Chemistry
397
438
.
N. Ya. Golovenko, A. V. Bogatskii, G. Yu. Kolomeichenko & S. A. Andronati. (1976) Relationship between the chemical structure, pharmacological activity, metabolism, and pharmacokinetics of certain tranquilizers of the 1,4-benzdiazepine series. Pharmaceutical Chemistry Journal 10:11, pages 1442-1445.
Crossref
Crossref
Francis R. Murphy, Vincent Krupa & Gerald S. Marks. (1976) Drug-induced porphyrin biosynthesis—XIV. Biochemical Pharmacology 25:12, pages 1351-1354.
Crossref
Crossref
A. Verloop, W. Hoogenstraaten & J. Tipker. 1976. Drug Design. Drug Design
165
207
.
Robert V. Smith & John P. Rosazza. (1975) Microbial Models of Mammalian Metabolism. Journal of Pharmaceutical Sciences 64:11, pages 1737-1759.
Crossref
Crossref
Maryse Beraud, Danielle Gaillard & Roger Derache. (1975) Relations entre la structure chimique de quinoxalines disubstituees en positions 2,3 et les activites de detoxication enzymatique des microsomes hepatiques du rat. Biochemical Pharmacology 24:16, pages 1505-1509.
Crossref
Crossref
Francis R. Murphy, Vincent Krupa & Gerald S. Marks. (1975) Drug-induced porphyrin biosynthesis—XIII. Biochemical Pharmacology 24:8, pages 883-889.
Crossref
Crossref
Corwin Hansch. 1975.
45
81
.
C.F. Wilkinson, Krystyna Hetnarski, G.Patricia Cantwell & Frederick J. Di Carlo. (1974) Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo. Biochemical Pharmacology 23:17, pages 2377-2386.
Crossref
Crossref
W.J. DunnIIIIII & Corwin Hansch. (1974) Chemicobiological interactions and the use of partition coefficients in their correlation. Chemico-Biological Interactions 9:2, pages 75-95.
Crossref
Crossref
D.W. Jones & R.S. Matthews. 1974.
159
203
.
J. Krieglstein & R. Stock. (1974) The isolated perfused rat brain as a model for studying drugs acting on the CNS. Psychopharmacologia 35:2, pages 169-177.
Crossref
Crossref
W.J. DunnIIIIII. 1973.
313
321
.
Corwin Hansch & John M. Clayton. (1973) Lipophilic Character and Biological Activity of Drugs II: The Parabolic Case. Journal of Pharmaceutical Sciences 62:1, pages 1-21.
Crossref
Crossref